Ammonium sulfate, as well as potassium phosphate, can be used to measure solubility differences between hemoglobin S and hemoglobin A. In addition, the solubility of deoxyhemoglobin CHarlem in 1.96 M phosphate has a markedly different temperature dependence from that of deoxyhemoglobin S. This observation indicates that the solubility measurement is quite sensitive to changes in protein structure. Because of the large degree of comparability between the solubility and the aggregation of deoxyhemoglobin S, solubility was used to measure the effectiveness of organic compounds as noncovalent modifiers of deoxyhemoglobin S aggregation.
has a markedly different temperature dependence from that of deoxyhemoglobin S. This observation indicates that the solubility measurement is quite sensitive to changes in protein structure. Because of the large degree of comparability between the solubility and the aggregation of deoxyhemoglobin S, solubility was used to measure the effectiveness of organic compounds as noncovalent modifiers of deoxyhemoglobin S aggregation.
Organic solvents (ethanol, dimethylsulfoxide, 1,4. dioxane, dimethylformamide) alter the solubility characteristics of deoxyhemoglobin S in 1.96 M phosphate buffer, pH 7.0. The concentrations of solvent necessary to provide a half-maximal effect are remarkably similar (about 0.5 M), although the chemical nature of these compounds is quite different. The effect of these solvents must be to prevent the noncovalent bond formation necessary to produce the insoluble hemoglobin precipitate, perhaps by altering the water structure around the deoxyhemoglobin S molecules. In addition to these organic solvents, guanidine hydrochloride and urea, two well-known protein denaturants, were studied. Guanidine hydrochloride was as effective as the best organic solvent in increasing the solubility of deoxyhemoglobin S; urea was far less effective. Studies in vitro with intact erythrocytes from individuals homozygous for hemoglobin S showed that sickling is decreased up to 50% by treatment with ethanol.
This offers further evidence that solubility is monitoring a phenomenon similar to the aggregation of deoxyhemoglobin S inside erythrocytes. While use of these particular compounds in vitro would seem to have no clinical implications, these studies do suggest that the use of chemicals that do not modify hemoglobin S covalently should be explored in efforts to prevent deoxyhemoglobin S aggregation.
Recently, chemical modifications of specific amino-acid residues on hemoglobin S have been actively studied as methods for inhibiting or reversing the macromolecular aggregation phenomenon observed with the deoxygenated form of the molecule (1) (2) (3) (4) (5) . In addition, the sickling of erythrocytes has been found to be inhibited by the use of high concentrations of urea, which acts in a noncovalent manner (6, 7) . Since the sickling phenomenon observed in erythrocytes is the result of formation of a large aggregate or aggregates of deoxygenated hemoglobin S, any disruption of the process involved in the interaction between deoxyhemoglobin S molecules could be helpful in maintaining the integrity of the erythrocyte and thus extending its lifetime. The ability to reverse the aggregation of deoxyhemoglobin S by lowering the temperature (8) and the disruption of gelation behavior by lowering the protein concentration clearly show that the interactions between deoxyhemoglobin S molecules are not covalent bonds.
In a previous study (9) (12, 13) , with 7.5% crosslinked polyacrylamide gels, Tris-glycine buffer (pH 8.6), and 4 mA per tube of 4-mm diameter.
The solubility of deoxyhemoglobin S was measured with 2 mg/ml of protein in a total volume of 1.0 ml that also contained 10 mg of Na2S2O4 and 1.96 M potassium phosphate buffer, pH 7.0, as described (9) . The effect of solvents or solutes on the solubility of deoxyhemoglobin S was determined by adding the solvent or solute to the phosphate buffer solution before addition of the hemoglobin. Identical results were obtained by adding the solvent to the hemoglobin before addition to the phosphate buffer.
The solubility of deoxyhemoglobin S in ammonium sulfate was measured by use of 2 mg/ml in a total volume of 1.0 ml of ammonium sulfate of different concentrations. Each reaction mixture contained 10 mg of NaA2O4 and 50 mM phosphate biiffer, pH 7.0, and was adjusted to pH 7.0 with NH40H before addition of the hemoglobin.
Hemoglobin CHarlem was obtained from a sample of blood kindly provided by Dr. R. Nagel. The hemoglobin CHariem was isolated by ion-exchange chromatography as described and shown to be pure by disc-gel electrophoresis.
The sickling of erythrocytes from individuals homozygous for hemoglobin S was determined by microscopy after deoxygenation of aliquots of whole blood with a moist gas mixture of 10% CO2 and 90% N2 at 370. The cells were fixed with deoxygenated 10% neutral formalin saline buffer (14) , and counted by two observers.
RESULTS
In order to test whether inorganic phosphate is required to obtain the observed solubility difference between hemoglobins S and A, the solubility of these hemoglobins was determined in various concentrations of ammonium sulfate. In Fig. 1 , the solubility of deoxyhemoglobin S and deoxyhemoglobin A as a function of ammonium sulfate concentration is seen. After incubation at 370 for 15 min in 2.5 M ammonium sulfate, deoxyhemoglobin S is found to be completely insoluble while deoxyhemoglobin A is completely soluble. Both oxyhemoglobins S and A were completely soluble under these conditions. In addition, deoxyhemoglobin S was found to be soluble in 2.5 M ammonium sulfate when the reaction mixture was incubated at 40 rather than 370.
As reported previously, the solubility of deoxyhemoglobin S was greatly dependent on pH (9). This was attributed to changes in the protein structure. To further study the role of protein structure on hemoglobin solubility, another hemoglobin, which is known to gel when deoxygenated, hemoglobin Clarlem, was examined. In Fig. 2 Fig. 3 Ethanol, 1,4-dioxane, and dimethylsulfoxide have very similar effects on the solubility of deoxyhemoglobin S and are only slightly less effective than dimethylformamide. In Table 1 the mean concentration of solvent necessary to obtain half-maximal solubility (1 mg of hemoglobin per ml remaining in filtrate) is shown. In addition, the effects of guanidine hydrochloride, urea, and acetone are also shown. Guanidine hydrochloride increases the solubility of deoxyhemoglobin S as effectively as dimethylformamide, while urea is found to be far less effective. No change in solubility of deoxyhemoglobin S was observed upon addition of up to 2 M glycerol to the reaction mixture. Attempts to study the effect of sodium dodecylsulfate on the solubility of deoxyhemoglobin S were unsuccessful because of the lack of solubility of sodium dodecylsulfate in 1.96 M phosphate buffer. Because of the dramatic effect some of these solvents have on the solubility of deoxyhemoglobin S and since there is evidence that interactions between deoxyhemoglobin S molecules are similar whether detected by solubility or sickling of cells, the effect of solvents on the sickling of erythrocytes was examined. In Table 2 the effect of ethanol on the sickling of erythrocytes from four different individuals homozygous for hemoglobin S is shown. Ethanol was added to samples of whole blood before deoxygenation by the gas mixture previously described. As Table 2 In Fig. 2 , the temperature dependence of the solubility of of deoxyhemoglobin CHarlem is compared with that of deoxyhemoglobin S. Hemoglobin Czarlem contains the normal S amino-acid substitution of postition j and a second substitution at position 73 of asparagine for aspartic acid (15) . Gelation of deoxyhemoglobin CHarlem has been found. to occur at a higher protein concentration than that of deoxyhemoglobin S (15) . This difference has been attributed to a difference in protein structure between hemoglobin S and hemoglobin CHarlem due to the second amino-acid substitution in' the beta subunit (16) . The fact that deoxyhemoglobin CHarlem is more soluble than deoxyhemoglobin S, as shown in Fig. 2, indicates that the solubility measurement is also sensitive to such changes in protein structure, therefore suggesting that solubility is measuring the same phenomenon as gelation. Because the solubility differences between deoxyhemoglobin S and deoxyhemoglobin A are not limited to a single type of salt solution and the solubility measurement is sensitive to changes in protein structure, the ability of noncovalent effectors to alter the solubility of deoxyhemoglobin S was examined. The results in Fig. 3 show that organic solvents are very effective in increasing the solubility of deoxyhemoglobin S. The concentration of dimethylformamide that produces a half-maximal effect is slightly lower than that obtained for ethanol, 1,4-dioxane, and dimethylsulfoxide (Table 1) . These solvents seem to prohibit the noncovalent bond formation necessary to produce the insoluble precipitate, perhaps by altering the water structure around the deoxyhemoglobin S molecules. The effect of these solvents is not related to their dielectric constants, which range from 45 In addition to the above solvents, two well-known protein denaturants, guanidine hydrochloride and urea, were studied. Guanidine hydrochloride was as effective as dimethylformamide in increasing the solubility of deoxyhemoglobin S; urea, on the other hand, is the least effective compound studied except for glycerol. Urea has been previously studied as an agent that inhibits gelation of deoxyhemoglobin S and sickling of erythrocytes (6, 7) .
Because the effect of organic solvents was so profound on the solubility of deoxyhemoglobin S, their effect on the sickling of hemoglobin S-containing erythrocytes in whole blood was tested. In Table 2 whether solubility is measuring a -similar phenomenon to the aggregation of deoxyhemoglobin S inside intact erythrocytes remains an open one. In 1.96 M phosphate, pH 7.0, or 2.5 M ammonium sulfate, deoxyhemoglobin S is insoluble while oxyhemoglobin S and oxy-and deoxyhemoglobin A are completely soluble. This insolubility is reversed by lowering the temperature or by addition of organic solvents. Oxy-and deoxyhemoglobin A become insoluble in 2.52 M phosphate, pH 7.0, and the insolubility of deoxyhemoglobin A is reversed by lowering the temperature. However, the insolubility of deoxyhemoglobin A is not affected by the addition of organic solvents. Therefore, the fact that noncovalent effectors such as organic solvents alter only the insolubility of deoxyhemoglobin S and also the sickling of red cells implies that solubility may be monitoring a phenomenon similar to the aggregation of deoxyhemoglobin S inside red cells and that noncovalent modifiers of the aggregation of deoxyhemoglobin S merit further investigation.
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